Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials

BACKGROUND: Diabetes is one of the most common chronic and costly diseases worldwide and type 2 diabetes is the most common type which accounts for about 90% of cases with diabetes. New medication-therapy regimens such as those containing linagliptin alone or in combination with other medications (w...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshavarz, Khosro, Lotfi, Farhad, Sanati, Ehsan, Salesi, Mahmood, Hashemi-Meshkini, Amir, Jafari, Mojtaba, Mojahedian, Mohammad M., Najafi, Behzad, Nikfar, Shekoufeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655990/
https://www.ncbi.nlm.nih.gov/pubmed/29070077
http://dx.doi.org/10.1186/s40199-017-0189-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655990/
https://www.ncbi.nlm.nih.gov/pubmed/29070077
http://dx.doi.org/10.1186/s40199-017-0189-6

Ejemplares similares